ANNUAL REPORT

Company

AYTU BIOPHARMA, INC

Filed

September 6, 2018

Period of Report

June 30, 2018

Accession Number

0001213900-18-012209

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →